These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 18440459)

  • 1. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control?
    Hiraki T; Mimura H; Gobara H; Sano Y; Fujiwara H; Date H; Kanazawa S
    J Vasc Interv Radiol; 2008 May; 19(5):706-11. PubMed ID: 18440459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors.
    Hiraki T; Sakurai J; Tsuda T; Gobara H; Sano Y; Mukai T; Hase S; Iguchi T; Fujiwara H; Date H; Kanazawa S
    Cancer; 2006 Dec; 107(12):2873-80. PubMed ID: 17096433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
    Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan.
    Yamakado K; Hase S; Matsuoka T; Tanigawa N; Nakatsuka A; Takaki H; Takao M; Inoue Y; Kanazawa S; Inoue Y; Sawada S; Kusunoki M; Takeda K
    J Vasc Interv Radiol; 2007 Mar; 18(3):393-8. PubMed ID: 17377185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.
    Hiraki T; Gobara H; Iishi T; Sano Y; Iguchi T; Fujiwara H; Tajiri N; Sakurai J; Date H; Mimura H; Kanazawa S
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1306-12. PubMed ID: 17976467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors influencing the development of an iatrogenic pneumothorax for computed tomography-guided radiofrequency ablation of upper renal tumor.
    Park BK; Kim CK
    Acta Radiol; 2008 Dec; 49(10):1200-6. PubMed ID: 19031183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
    Fernando HC; De Hoyos A; Landreneau RJ; Gilbert S; Gooding WE; Buenaventura PO; Christie NA; Belani C; Luketich JD
    J Thorac Cardiovasc Surg; 2005 Mar; 129(3):639-44. PubMed ID: 15746749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.
    Pennathur A; Luketich JD; Abbas G; Chen M; Fernando HC; Gooding WE; Schuchert MJ; Gilbert S; Christie NA; Landreneau RJ
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):857-64. PubMed ID: 17903496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas [corrected].
    Nakamura T; Matsumine A; Yamakado K; Matsubara T; Takaki H; Nakatsuka A; Takeda K; Abo D; Shimizu T; Uchida A
    Cancer; 2009 Aug; 115(16):3774-81. PubMed ID: 19514086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
    Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
    Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
    Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
    J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Inoue K; Nakamura K; Inoue Y
    J Vasc Interv Radiol; 2007 Mar; 18(3):399-404. PubMed ID: 17377186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
    Linden PA; Wee JO; Jaklitsch MT; Colson YL
    Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
    Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation with internally cooled versus perfused electrodes for the treatment of small hepatocellular carcinoma in patients with cirrhosis.
    Seror O; N'Kontchou G; Tin-Tin-Htar M; Barrucand C; Ganne N; Coderc E; Trinchet JC; Sellier N; Beaugrand M
    J Vasc Interv Radiol; 2008 May; 19(5):718-24. PubMed ID: 18440461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.
    Elias D; De Baere T; Smayra T; Ouellet JF; Roche A; Lasser P
    Br J Surg; 2002 Jun; 89(6):752-6. PubMed ID: 12027986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
    Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
    J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
    Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
    Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
    Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
    J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates.
    Herrera LJ; Fernando HC; Perry Y; Gooding WE; Buenaventura PO; Christie NA; Luketich JD
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):929-37. PubMed ID: 12698158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.